Fundraising Fox

Ray Therapeutics

San Francisco, US · Founded 2021 · Delaware corporation · 3 known investors

Restoring vision through optogenetics.

Biotech

Founders & leadership

TA
Tiba AynechiDirector
DK
Dmitry KuzminDirector
SA
Sean AinsworthExecutive Officer, Director
RC
Raymond CamahortDirector
HC
Hannah ChangDirector
GA
Gary AbramsDirector
PB
Paul BresgeExecutive Officer, Director

Investors · 3

MRL Ventures FundCambridge · $25M
4Bio VenturesreportedLondon
Norwest Venture PartnersreportedMenlo Park · $10M – $30Mvia Tiba Aynechi · board

Reported raises · per SEC filings

Form D private placements
▶$14MraisedMay 2023 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tiba AynechiDirector
  • Dmitry KuzminDirector
  • Sean AinsworthExecutive Officer, Director
  • Raymond CamahortDirector
  • Hannah ChangDirector
  • Gary AbramsDirector
  • Paul BresgeExecutive Officer, Director
Offering amount
$100M
Amount sold
$14M
First sale
May 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedApr 2022 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul BresgeExecutive Officer, Director
  • Gary AbramsDirector
  • Dmitry KuzminDirector
  • Sean AinsworthExecutive Officer, Director
  • Cameron GallagherDirector
  • Andrew HowardExecutive Officer
Offering amount
$6M
Amount sold
$6M
First sale
May 2021
Incorporated
Corporation, California, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.